Pregnancy rates and predictors of conception, miscarriage and abortion in US women with HIV

AIDS

Volumn 18, Issue 2, 2004, Pages 281-286

  Massad, L Stewart ^a,j   Springer, Gayle ^b   Jacobson, Lisa ^b   Watts, Heather ^c   Anastos, Kathryn ^d   Korn, Abner ^e   Cejtin, Helen ^f   Stek, Alice ^g   Young, Mary ^h   Schmidt, Julie ^f   Minkoff, Howard ⁱ  

^a SOUTHERN ILLINOIS UNIVERSITY   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^d LINCOLN MEDICAL AND MENTAL HEALTH CENTER   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f Jr Hospital of Cook County   (United States)

^g UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^h GEORGETOWN UNIVERSITY   (United States)

ⁱ MAIMONIDES MEDICAL CENTER   (United States)

^j SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

more..

Author keywords

AIDS; HAART; HIV; Pregnancy outcome

Indexed keywords

ABACAVIR; ANTIRETROVIRUS AGENT; PROTEINASE INHIBITOR; RITONAVIR; RNA DIRECTED DNA POLYMERASE INHIBITOR; SAQUINAVIR; STAVUDINE; TENOFOVIR; ZIDOVUDINE;

ABORTION; ADULT; ARTICLE; CONCEPTION; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; ECTOPIC PREGNANCY; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; PREGNANCY RATE; PRIORITY JOURNAL; RISK FACTOR; SERODIAGNOSIS; SPONTANEOUS ABORTION; STILLBIRTH; TREATMENT OUTCOME; UNITED STATES;

ABORTION, INDUCED; ABORTION, SPONTANEOUS; ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; COHORT STUDIES; FEMALE; FERTILIZATION; HIV INFECTIONS; HIV SERONEGATIVITY; HIV SEROPOSITIVITY; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREGNANCY OUTCOME; PREGNANCY RATE; PROSPECTIVE STUDIES; REGRESSION ANALYSIS; RISK FACTORS; UNITED STATES;

EID: 10744232397     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-200401230-00018     Document Type: Article

References (22)

1. Wilson TE, Massad LS, Riester KA, Barkan S, Richardson J, Young M, et al. Sexual, contraceptive, and drug use behaviors of women with HIV and those at high risk for infection: results from the Women's Interagency HIV Study. AIDS 1999, 13:591-598.
2. Chu SY, Hanson DL, Jones JL. Pregnancy rates among women infected with human immunodeficiency virus. Obstet Gynecol 1996, 87:195-198.
3. Anastos K, Kalish LA, Hessol N, Weiser B, Melnick S, Bums D, et al. The relative value of CD4 cell count and quantitative HIV-1 RNA in predicting survival in HIV-1 infected women: results of the Women's Interagency HIV Study. AIDS 1999, 13:1717-1726.
4. Minkoff H, Ahdieh L, Watts H, Greenblatt RM, Schmidt J, Schneider M, et al. The relationship of pregnancy to the use of highly active antiretroviral therapy. Am J Obstet Gynecol 2001, 184:1221-1227.
5. Watts DH. Management of human immunodeficiency virus infection in pregnancy. New Engl J Med 2002, 346:1879-1891.
6. Hankins C, Tran T, Lapointe N. Sexual behavior and pregnancy outcome in HIV-infected women. Canadian Women's HIV Study Group. J Acquire Immune Defic Syndr Hum Retrovirol 1998, 18:479-487.
7. Bongain A, Berrebi A, Marin-Barjoan E, Dunais B, Thene M, Pradier C, Gillet JY. Changing trends in pregnancy outcome among HIV-infected women between 1985 and 1997 in 529 southern French university hospitals. Eur J Obstet Gynecol Reprod Biol 2002, 104:124-128.
8. van Benthem BHB, de Vincenzi I, Delmas MC, Larsen C, van den Hoek A, Prins M. Pregnancies before and after HIV diagnosis in a European cohort of HIV-infected women. AIDS 2000, 14:2171-2178.
9. Selwyn PA, Carter RJ, Schoenbaum EE, Robertson VJ, Slein RS, Rogers MF. Knowledge of HIV antibody status and decisions to continue or terminate pregnancy among intravenous drug users. JAMA 1989, 261:3567-3571.
10. Johnstone FD, Brettle RP, MacCallum LR, Mok J, Peutherer JF, Burns S. Women's knowledge of their HIV antibody state: its effect on their decision whether to continue the pregnancy. BMJ 1990, 300:23-24.
11. Sunderland A, Minkoff HL, Handte J, Moroso G, Landesman S. The impact of human immunodeficiency virus serostatus on reproductive decisions of women. Obstet Gynecol 1992, 79:1027-1031.
12. Kline A, Strickler J, Kempf J. Factors associated with pregnancy and pregnancy resolution in HIV seropositive women. Soc Sci Med 1995, 40:1539-1547.
13. Stephenson JM, Griffioen A. The effect of HIV diagnosis on reproductive experience. AIDS 1996, 10:1683-1687.
14. Thackway SV, Furner V, Mijch A, Cooper DA, Holland D, Martinez P, et al. Fertility and reproductive choice in women with HIV-1 infection. AIDS 1997, 11:663-667.
15. Smits AK, Goergen CA, Delaney JA, Williamson C, Mundy LM, Fraser VJ. Contraceptive use and pregnancy decision making among women with HIV. AIDS Patient Care STDs 1999, 13:739-746.
16. Bedimo AL, Bessinger R, Kissinger P. Reproductive choices among HIV-positive women. Soc Sci Med 1998, 46:171-179.
17. Brocklehurst P, French R. The association between maternal HIV infection and perinatal outcome: a systematic review of the literature and meta-analysis. Br J Obstet Gynecol 1998, 103:836-848.
18. Barkan SE, Melnick SL, Preston-Martin S, Weber K, Kalish LA, Miotti P, et al. The Women's Interagency HIV Study. Epidemiology 1998, 9:117-125.
19. Cook JA, Cohen MH, Grey D, Kirstein L, Burke J, Anastos K, et al. Use of highly active antiretroviral therapy in a cohort of HIV-seropositive women. Am J Public Health 2002, 92:82-87.
20. Gange SJ, Barron Y, Greenblatt RM, Anastos K, Minkoff H, Young M, et al. Effectiveness of highly active antiretroviral therapy among HIV-1 infected women. J Epidemiol Community Health 2002, 36:153-159.
21. Johnstone FD, Hamilton BA. The effect of human immunodeficiency virus infection and drug use on birth characteristics. Obstet Gynecol 1996, 88:321-326.
22. Lindsay MK, Grant J, Peterson HB, Willis S, Nelson P, Klein L. The impact of knowledge of human immunodeficiency virus serostatus on contraceptive choice and repeat pregnancy. Obstet Gynecol 1995, 83:675-679.